Global IVD Companies Report Second Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leade…

Read More

---

September 23, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue

One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki t…

Read More

---

September 3, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 12 – September 3, 2024 Issue

To challenge the federal Food and Drug Administration (FDA) final rule on laboratory developed tests (LDTs,) the Association for Molecular Pathology (AMP) filed a lawsuit on August 20, 2024, in the United States District Court for the Southern District of Tex…

Read More

---

2023 Ranking of the World’s Top 13 IVD Corporations

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. Th…

Read More

---

2022 Ranking of the World’s Top 12 IVD Corporations

By Scott Wallask | From the Volume XXX, No. 11 – July 31, 2023 Issue

WHILE THE TOP FOUR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS kept their collective hold on the market compared to 2021, the big surprise was that Thermo Fisher Scientific’s…

Read More

---

Elizabeth Holmes’ Appeal Questions Competence of CLIA Lab Director

By Scott Wallask | From the Volume XXX No. 4 – March 6, 2023 Issue

TANTALIZING DETAILS ABOUT FORMER THERANOS CEO ELIZABETH HOLMES’ purchase of a one-way plane ticket to Mexico prior to her conviction grabbed headlines following the filing of a motion to appeal her conviction.  However, for clinical labo…

Read More

---

QuidelOrtho Earns $3.3 Billion in First Year as Combined Firm

By Robert Michel | From the Volume XXX No. 4 – March 6, 2023 Issue

IN OUR FEBRUARY 13, 2023, ISSUE OF THE DARK REPORT, we analyzed the 2022 full-year and Q4 earnings of major IVD companies. At the time our prior issue went to press, QuidelOrtho had not yet reported its year-end results.  …

Read More

---

Top Public IVD Companies Report Q3/Q4 2022 Earnings

By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue

IT WAS A MIXED BAG OF THIRD QUARTER FINANCIAL RESULTS for the nation’s largest in vitro diagnostics (IVD) manufacturers, with COVID-19 testing volume a contributing factor.  Fluctuating demand for SARS-CoV-2 testing proved perplexing, as some IV…

Read More

---

2021 Rankings of the World’s Top 12 IVD Companies

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

WHILE THERE WAS SOME JOCKEYING FOR NEW positions, in vitro diagnostics (IVD) manufacturers remain entrenched in their market based on The Dark Report’s 2021 ranking of the Top 12 IVD Companies.  COVID-1…

Read More

---

Amazon to Close Employee COVID-19 Testing Lab in Ky.

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

IN A MOVE THAT MAY SURPRISE SOME OBSERVERS, Amazon announced it will close its COVID-19 employee testing laboratory in Hebron, Ky., which is just across the Ohio River from Cincinnati.  This is the second large COVID-19 clinical laboratory to publ…

Read More

---